Summary of Classification and Labelling
Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation)
General Information
Index Number EC / List no.

EC: European Community number/ List no.: List number assigned by ECHA.

List Numbers are purely technical identifiers for processing a submission via REACH-IT. More information: https://echa.europa.eu/information-on-chemicals/registered-substances/information

CAS Number International Chemical Identification
008-003-00-9 231-765-0 7722-84-1 hydrogen peroxide solution ...%

ATP Inserted / Updated: CLP00 This field indicates when an entry in Annex VI to CLP has been inserted and/or updated with an Adaptation to Technical Progress (ATP) to the CLP Regulation.
CLP Classification (Table 3.1)
Classification Labelling Specific Concentration limits, M-Factors Notes
Hazard Class and Category Code(s) Hazard Statement Code(s) Hazard Statement Code(s) Supplementary Hazard Statement Code(s) Pictograms, Signal Word Code(s)
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Corr. 1B; H314: 50 % ≤ C < 70 %
-: STOT SE 3; H335; C ≥ 35 %
Ox. Liq. 2; H272: 50 % ≤ C < 70 % ****
Eye Dam. 1; H318: 8 % ≤ C < 50 %
Skin Corr. 1A; H314: C ≥ 70 %
Eye Irrit. 2; H319: 5 % ≤ C < 8 %
Ox. Liq. 1; H271: C ≥ 70 %****
Skin Irrit. 2; H315: 35 % ≤ C < 50 %
Note B
Acute Tox. 4 * H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 * H332 H332

Signal Words Pictograms
Danger
GHS03
Flame over circle
GHS05
Corrosion
GHS07
Exclamation mark
Seveso III Data
Disclaimer: Please note that some of the substances covered by the Seveso Directive can belong to more than one Seveso categories. It will be up to the users to decide whether their substance or mixture fall in one or in more of these classification categories depending on the tonnage bands and the concentrations.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.

Seveso Data
Seveso Substance Seveso Categories
Yes P8
Notified classification and labelling
General Information
EC / List no.

EC: European Community number/ List no.: List number assigned by ECHA.

List Numbers are purely technical identifiers for processing a submission via REACH-IT. More information: https://echa.europa.eu/information-on-chemicals/registered-substances/information

Name CAS Number
The CAS number associated with this substance in the EC Inventory and/or REACH-IT is reported here. In some cases, e.g. for differently hydrated forms of the same substance, alternative CAS numbers have been notified. In those cases, the additional CAS numbers are published in the column “additional notified information” below.
231-765-0 Hydrogen peroxide 7722-84-1

Notified classification and labelling according to CLP criteria
Classification Labelling Specific Concentration limits, M-Factors Notes Classification affected by Impurities / Additives

This check appears when a notifier has indicated that an impurity or an additive present in the substance impacts the notified classification. ECHA cannot reveal the identity of the impurity/additive or determine the exact impact it has on the classification.

Additional Notified Information

State/form: The notified state/form of the substance for all notifications classifying in this manner is reported under this link. Additional CAS number(s): Occasionally, a notification contains a different CAS number than the one reported under the general information section above. In those cases, all different notified CAS numbers associated with the aggregated classification are reported under this link. IUPAC name(s): Publicly available IUPAC names from all notifications classifying in this manner are reported under this link.

Number of Notifiers

This number indicates how many companies notified this classification. All members of a REACH registration joint submission and all participants in a group of manufacturers/importers who notified are counted. The grouping is done automatically with no manual verification.

Joint Entries

This check appears when a classification comes from a lead dossier of a REACH registration joint submission. When a member submits a classification separately under Article 11(3) of REACH (opt-out), this classification is displayed separately and not marked as a joint entry.

Hazard Class and Category Code(s) Hazard Statement Code(s) Hazard Statement Code(s) Supplementary Hazard Statement Code(s) Pictograms, Signal Word Code(s)
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Irrit. 2; : 35 % ≤ C < 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Corr. 1A; : C ≥ 70 %
Eye Dam. 1; : 8 % < C < 50 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Ox. Liq. 1; : C ≥ 70 %
STOT SE 3; : C ≥ 35 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Aquatic Chronic 3; : C ≥ 63 %
Note B
State/Form
IUPAC Names
32 yes View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H332 H332
STOT SE 3 H335 (Respiratory tra...) (Inhalation) H335
Aquatic Chronic 3 H412 H412
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Corr. 1B; : 50 % ≤ C < 70 %
Ox. Liq. 1; : C ≥ 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
STOT SE 3; : C ≥ 35 %
Skin Corr. 1A; : C ≥ 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Note B
State/Form
IUPAC Names
422 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Note B
355 View details
Acute Tox. 4 H302  
  H302+H332
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 4 H332  
STOT SE 3 H335 (unknown) H335
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Ox. Liq. 1; : C ≥ 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Note B
90 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 2 H272 H272 GHS03
GHS05
GHS07
Dgr
80 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 4 H332 H332
STOT SE 3 H335 (various) H335
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Ox. Liq. 1; : C ≥ 70 %
STOT SE 3; : C ≥ 35 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Corr. 1A; : C ≥ 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
State/Form
IUPAC Names
67 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
State/Form
IUPAC Names
63 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
Dgr
Skin Corr. 1A; : C ≥ 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Ox. Liq. 2; : 50 % < C < 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
STOT SE 3; : C ≥ 35 %
Skin Corr. 1B; : 50 % < C < 70 %
Ox. Liq. 1; : C ≥ 70 %
IUPAC Names 61 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 3 H331 H331
Ox. Liq. 1 H271 H271 EUH071
GHS03
GHS05
GHS07
Dgr
State/Form
45 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 4 H332 H332
Acute Tox. 4 H302 H302 GHS05
GHS07
Dgr
State/Form
IUPAC Names
44 View details
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Eye Irrit. 2; : 5 % ≤ C < 8 %
Ox. Liq. 1; : C ≥ 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
STOT SE 3; : C ≥ 35 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
State/Form
IUPAC Names
38 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Flam. Liq. 2 H225 H225 GHS02
GHS05
Dgr
State/Form
37 View details
Skin Corr. 1B H314 H314
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Eye Dam. 1; : 5 % ≤ C < 8 %
Ox. Liq. 1; : C > 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Eye Irrit. 2; : C ≥ 35 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Corr. 1A; : C ≥ 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
STOT SE 3; : C ≥ 35 %
State/Form
34 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 4 H332 H332
STOT SE 3 H335 (Respiratory Tra...) H335
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Irrit. 2; : 35 % ≤ C < 50 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Ox. Liq. 1; : C ≥ 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
STOT SE 3; : C ≥ 35 %
IUPAC Names 30 View details
Acute Tox. 4 H302  
  H302+H332
Skin Corr. 1A H314 H314
Acute Tox. 4 H332  
STOT SE 3 H335 (respiratory tra...) H335
Aquatic Chronic 3 H412 H412
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Irrit. 2; : C ≥ 50 %
Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Eye Dam. 1; : C ≥ 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Ox. Liq. 1; : C ≥ 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
STOT SE 3; : C ≥ 35 %
Note B
State/Form
IUPAC Names
29 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Corr. 1A; : 50 % ≤ C < 70 %
STOT SE 3; : C ≥ 35 %
Skin Corr. 1B; : 35 % ≤ C < 50 %
Ox. Liq. 1; : C ≥ 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Note B
State/Form
28 View details
  H302
Acute Tox. 4 H312  
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Ox. Liq. 1; : C ≥ 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
STOT SE 3; : C ≥ 35 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Eye Dam. 1; : 8 % ≤ C < 50 %
State/Form
27 View details
Acute Tox. 4 H302  
Skin Corr. 1A H314  
Eye Dam. 1 H318 H318
  H319
Acute Tox. 4 H332  
  H335
Aquatic Chronic 3 H412  
  H271 Dgr
24 View details
  H302
  H314
  H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
Dgr
State/Form
22 View details
Acute Tox. 4 H302 H302
Skin Corr. 1B H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
STOT SE 3; : C ≥ 35 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Ox. Liq. 1; : C ≥ 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
State/Form
IUPAC Names
19 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
STOT SE 3 H335 (not specified) H335
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS06
Dgr
Eye Irrit. 2; : 5 % ≤ C ≤ 8 %
Ox. Liq. 2; : 50 % ≤ C ≤ 70 %
Eye Dam. 1; : 8 % ≤ C ≤ 50 %
Ox. Liq. 1; : C ≥ 70 %
Skin Corr. 1B; : 50 % ≤ C ≤ 70 %
Skin Corr. 1A; : C ≥ 70 %
STOT SE 3; : C ≥ 35 %
State/Form
IUPAC Names
18 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 3 H331 H331
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Eye Irrit. 2; : 5 % ≤ C < 8 %
Eye Dam. 1; : 8 % ≤ C < 50 %
STOT SE 3; : C ≥ 35 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Ox. Liq. 1; : C > 70 %
State/Form
18 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H332 H332
STOT SE 3 H335 (Respiratory Tra...) H335
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Eye Irrit. 2; : 5 % ≤ C < 8 %
STOT SE 3; : C ≥ 35 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 1; : C ≥ 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Note B
State/Form
IUPAC Names
18 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
STOT SE 3 H335 (data lacking) H335
Ox. Liq. 1 H271 H271 Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 1; : C ≥ 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
STOT SE 3; : C ≥ 35 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
State/Form
16 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
15 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 4 H332 H332
STOT SE 3 H335 (RTI) H335
Aquatic Chronic 3 H412 H412
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
IUPAC Names 15 View details
  H302
  H314
  H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
STOT SE 3; : C ≥ 35 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Ox. Liq. 1; : C ≥ 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Note B
IUPAC Names 11 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Aquatic Chronic 3 H412 H412
Ox. Liq. 1 H271 H271 GHS09
GHS03
GHS05
GHS07
Dgr
State/Form
10 View details
Met. Corr. 1 H290 H290
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H332 H332
STOT SE 3 H335 (lung) H335
Aquatic Chronic 2 H411 H411
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Corr. 1A; : C ca. 70 %
Eye Dam. 1; : 8 % ca. C < 50 %
Skin Irrit. 2; : 35 % ca. C < 50 %
STOT SE 3; : C ca. 35 %
Skin Corr. 1B; : 50 % ca. C < 70 %
Eye Irrit. 2; : 5 % ca. C < 8 %
IUPAC Names 7 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Irrit. 2; : C ≥ 35 %
Eye Dam. 1; : C ≥ 8 %
Ox. Liq. 2; : C ≥ 50 %
Eye Irrit. 2; : C ≥ 5 %
Skin Corr. 1B; : C ≥ 50 %
Ox. Liq. 1; : C ≥ 70 %
Skin Corr. 1A; : C ≥ 70 %
Note B
State/Form
7 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Corr. 1B; : 50 % ≤ C < 70 %
Aquatic Chronic 3; : C ≥ 25 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Eye Dam. 1; : 8 % ca. C < 50 %
STOT SE 3; : C ≥ 35 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 1; : C ≥ 70 %


M(Chronic)=1
Note B
IUPAC Names 6 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H332 H332
STOT SE 3 H335 (Respiratory tra...) (Inhalation) H335
Aquatic Chronic 3 H412 H412
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Corr. 1A; : C ca. 70 %
STOT SE 3; : C ca. 35 %
Skin Corr. 1B; : 50 % ca. C < 70 %
Eye Irrit. 2; : 5 % ca. C < 8 %
Eye Dam. 1; : 8 % ca. C < 50 %
Skin Irrit. 2; : 35 % ca. C < 50 %
Note B
IUPAC Names 6 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
STOT SE 3; : C ≥ 35 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 70 %
STOT SE 1; : C ≥ 35 %
Ox. Liq. 1; : C ≥ 70 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
State/Form
5 View details
Acute Tox. 4 H302  
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H332  
Aquatic Chronic 3 H412 H412
  H271 GHS03
GHS05
GHS07
Dgr
Skin Irrit. 2; : 35 % ≤ C < 50 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Ox. Liq. 1; : C ≥ 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
STOT SE 3; : C ≥ 35 %
Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
5 View details
  H302
  H314
  H318
  H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
4 View details
Acute Tox. 4 H302 H302
Acute Tox. 4 H312  
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
  H332
STOT SE 3 H335 (Respiratory tra...) H335
Ox. Liq. 1 H271 H271 (H271) GHS03
GHS05
GHS07
Dgr
Note B
IUPAC Names 4 View details
Acute Tox. 4 H302 H302 (H302)
Skin Corr. 1A H314 H314 (H314)
Acute Tox. 4 H332 H332 (H332)
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Eye Dam. 1; : 8 % ≤ C < 100 %
Skin Corr. 1C; : 50 % ≤ C < 70 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Corr. 1A; : 70 % ≤ C < 100 %
Ox. Liq. 1; : 70 % ≤ C < 100 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Note B
2 View details
  H272
Acute Tox. 4 H302  
  H302+H332
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H332  
Not Classified               2  
Ox. Liq. 1 H271   Dgr
IUPAC Names 2 View details
Acute Tox. 4 H302  
Skin Corr. 1A H314  
Acute Tox. 4 H332  
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Corr. 1B; : 50 % ≤ C < 70 %
STOT SE 3; : C ≥ 35 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Ox. Liq. 1; : C ≥ 70 %
Note B
State/Form
IUPAC Names
2 View details
Met. Corr. 1 H290 H290
Acute Tox. 4 H302  
  H302+H332
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H332  
Aquatic Chronic 3 H412 H412
  H302 GHS03
GHS05
Dgr
State/Form
1 View details
Acute Tox. 4 H302 H302 GHS05
GHS07
Dgr
Note B
yes State/Form
IUPAC Names
1 View details
Eye Dam. 1 H318 H318
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Ox. Liq. 1; : 70 % ≤ C ≤ 100 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Corr. 1A; : 70 % ≤ C ≤ 100 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
STOT SE 3; : 35 % ≤ C ≤ 100 %
IUPAC Names 1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Corr. 1B; : 50 % ≤ C < 70 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Note B
IUPAC Names 1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Skin Corr. 1A; : C ≥ 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Eye Dam. 1; : 8 % ≤ C < 50 %
STOT SE 3; : C ≥ 35 %
Ox. Liq. 1; : C ≥ 70 %
Note B
State/Form
IUPAC Names
1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
STOT SE 3 H335 (not known) H335
Aquatic Chronic 3 H412 H412
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Note B
IUPAC Names 1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Irrit. 2; : 35 % ≤ C < 50 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Ox. Liq. 1; : C ≥ 70 %
Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
STOT SE 3; : C ≥ 35 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Note B
IUPAC Names 1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H332 H332
STOT SE 3 H335  
Aquatic Chronic 3 H412  
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Ox. Liq. 1; : C > 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
STOT SE 3; : C ≥ 35 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 70 %
State/Form
1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 4 H332 H332
STOT SE 3 H335 (Respiratory Tra...) H335
  H271 (H332; H302; H31...) GHS03
GHS05
GHS07
Dgr
State/Form
1 View details
Ox. Liq. 2 H272 H272 GHS03
GHS05
GHS07
Dgr
STOT SE 3; : C ≥ 35 %
Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 1; : C ≥ 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
State/Form
IUPAC Names
1 View details
Acute Tox. 4 H302 H302
Eye Dam. 1 H318 H318
Ox. Liq. 2 H272 H272 GHS03
GHS05
GHS07
Dgr
Ox. Liq. 2; : 50 % ≤ C < 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
STOT SE 3; : C ≥ 35 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Ox. Liq. 1; : C ≥ 70 %
Skin Corr. 1A; : C ≥ 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Note B
IUPAC Names 1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1B H314 H314
Acute Tox. 4 H332 H332
  H335
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Corr. 1A; : C ≥ 70 %
Ox. Liq. 1; : C ≥ 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
STOT SE 3; : C ≥ 35 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Note B
State/Form
IUPAC Names
1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H332 H332
STOT SE 3 H335 (Respiratory sys...) (Inhalation) H335
Aquatic Chronic 3 H412 H412
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Corr. 1B; : 50 % ≤ C < 70 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
STOT SE 3; : 35 % ≤ C < 100 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Ox. Liq. 1; : 70 % ≤ C < 100 %
Skin Corr. 1C; : 50 % ≤ C < 70 %
Skin Corr. 1A; : 70 % ≤ C < 100 %
Eye Dam. 1; : 8 % ≤ C < 100 %
Note B
1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H332 H332
STOT SE 3 H335 (Not applicable) H335
Ox. Liq. 1 H271   GHS05
GHS07
Dgr
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Ox. Liq. 1; : C ≥ 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
STOT SE 3; : C ≥ 35 %
Skin Corr. 1A; : C ≥ 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Eye Dam. 1; : 35 % ≤ C ≤ 50 %
IUPAC Names 1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314  
  H315
  H318
Acute Tox. 4 H332  
  H335
Acute Tox. 4 H302 H302 GHS05
GHS07
Dgr
State/Form
IUPAC Names
1 View details
Eye Dam. 1 H318 H318
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Corr. 1A; : 70 % ≤ C ≤ 100 %
Ox. Liq. 1; : 70 % ≤ C ≤ 100 %
STOT SE 3; : 35 % ≤ C ≤ 100 %
Skin Irrit. 2; : 35 % ≤ C ≤ 50 %
Eye Dam. 1; : 8 % ≤ C ≤ 50 %
Ox. Liq. 2; : 50 % ≤ C ≤ 70 %
Eye Irrit. 2; : 5 % ≤ C ≤ 8 %
Skin Corr. 1B; : 50 % ≤ C ≤ 70 %
Note B
IUPAC Names 1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 4 H332 H332
STOT SE 3 H335 (Unknown) (Oral) H335
Acute Tox. 4 H302   GHS07
Dgr
Skin Irrit. 2; : 5 % ≤ C < 8 %
-; : 5 % ≤ C < 8 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
State/Form
IUPAC Names
1 View details
  H302+H332
Skin Irrit. 2 H315 H315
Eye Irrit. 2 H319 H319
Acute Tox. 4 H332  
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
GHS06
Dgr
1 View details
Acute Tox. 3 H301 H301
Skin Corr. 1B H314 H314
Acute Tox. 2 H330 H330
STOT SE 3 H335 (RESPIRATORY TRA...) H335
Ox. Liq. 1 H271   GHS05
GHS07
Dgr
Eye Dam. 1; : 8 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
STOT SE 3; : C ≥ 35 %
Ox. Liq. 1; : C ≥ 70 %
Note B
State/Form
IUPAC Names
1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314  
  H318
Acute Tox. 4 H332  
Ox. Liq. 1 H271   GHS07
Wng
Eye Irrit. 2; : C ca. 2 %
State/Form
IUPAC Names
1 View details
Acute Tox. 4 H302  
Skin Corr. 1A H314  
  H319
Acute Tox. 4 H332  
Acute Tox. 4 H302 H302 GHS05
GHS07
Dgr
State/Form
1 View details
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 4 H332 H332
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Skin Corr. 1B; : 50 % ≤ C < 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
STOT SE 3; : 35 % ≤ C < 100 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Skin Corr. 1C; : 50 % ≤ C < 70 %
Ox. Liq. 1; : 70 % ≤ C < 100 %
Skin Corr. 1A; : 70 % ≤ C < 100 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Note B
1 View details
  H272
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H332 H332
STOT SE 3 H335 (Not applicable) H335
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
Ox. Liq. 1; : C ≥ 70 %
STOT SE 3; : C ≥ 35 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Note B
State/Form
IUPAC Names
1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
  H318
Acute Tox. 4 H332 H332
  H335
Ox. Liq. 1 H271 H271 GHS03
GHS05
GHS07
Dgr
STOT SE 3; : C ≥ 35 %
Skin Corr. 1B; : 50 % ≤ C < 70 %
Skin Corr. 1A; : C ≥ 70 %
Eye Dam. 1; : 8 % ≤ C < 50 %
Ox. Liq. 2; : 50 % ≤ C < 70 %
Skin Irrit. 2; : 35 % ≤ C < 50 %
Ox. Liq. 1; : C ≥ 70 %
Eye Irrit. 2; : 5 % ≤ C < 8 %
State/Form
IUPAC Names
1 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Acute Tox. 4 H332 H332
STOT SE 3 H335 (Respiratory tra...) (Inhalation) H335

Number of Aggregated Notifications: 64